| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TFEB SOX30 SIX4 KMT2D SALL2 NFATC3 NFIC CARF ELF4 DLX2 GRHL3 ZNF292 | 1.02e-04 | 560 | 116 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TFEB SOX30 SIX4 KMT2D SALL2 NFATC3 NFIC CARF ELF4 DLX2 GRHL3 ZNF292 | 1.13e-04 | 566 | 116 | 12 | GO:0001216 |
| GeneOntologyCellularComponent | PML body | 5.93e-06 | 125 | 115 | 7 | GO:0016605 | |
| GeneOntologyCellularComponent | methyltransferase complex | 3.28e-04 | 108 | 115 | 5 | GO:0034708 | |
| Domain | FYrich_C | 2.14e-06 | 5 | 113 | 3 | IPR003889 | |
| Domain | FYrich_N | 2.14e-06 | 5 | 113 | 3 | IPR003888 | |
| Domain | FYRC | 2.14e-06 | 5 | 113 | 3 | SM00542 | |
| Domain | FYRN | 2.14e-06 | 5 | 113 | 3 | SM00541 | |
| Domain | FYRN | 2.14e-06 | 5 | 113 | 3 | PF05964 | |
| Domain | FYRC | 2.14e-06 | 5 | 113 | 3 | PF05965 | |
| Domain | FYRC | 2.14e-06 | 5 | 113 | 3 | PS51543 | |
| Domain | FYRN | 2.14e-06 | 5 | 113 | 3 | PS51542 | |
| Domain | Post-SET_dom | 1.14e-04 | 16 | 113 | 3 | IPR003616 | |
| Domain | PostSET | 1.14e-04 | 16 | 113 | 3 | SM00508 | |
| Domain | POST_SET | 1.14e-04 | 16 | 113 | 3 | PS50868 | |
| Domain | EPHD | 3.05e-04 | 22 | 113 | 3 | PS51805 | |
| Domain | ZF_CXXC | 1.93e-03 | 11 | 113 | 2 | PS51058 | |
| Domain | Znf_CXXC | 1.93e-03 | 11 | 113 | 2 | IPR002857 | |
| Domain | zf-CXXC | 1.93e-03 | 11 | 113 | 2 | PF02008 | |
| Domain | SET | 1.94e-03 | 41 | 113 | 3 | PF00856 | |
| Domain | PHD | 2.09e-03 | 89 | 113 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.27e-03 | 91 | 113 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.65e-03 | 95 | 113 | 4 | PS50016 | |
| Domain | SET | 2.71e-03 | 46 | 113 | 3 | SM00317 | |
| Domain | ZF_PHD_1 | 2.75e-03 | 96 | 113 | 4 | PS01359 | |
| Domain | SET_dom | 3.44e-03 | 50 | 113 | 3 | IPR001214 | |
| Domain | SET | 3.44e-03 | 50 | 113 | 3 | PS50280 | |
| Domain | HMG_box | 4.05e-03 | 53 | 113 | 3 | PF00505 | |
| Domain | HMG | 4.27e-03 | 54 | 113 | 3 | SM00398 | |
| Domain | Cadherin_CS | 4.34e-03 | 109 | 113 | 4 | IPR020894 | |
| Domain | - | 4.50e-03 | 55 | 113 | 3 | 1.10.30.10 | |
| Domain | CADHERIN_1 | 4.93e-03 | 113 | 113 | 4 | PS00232 | |
| Domain | Cadherin | 4.93e-03 | 113 | 113 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 5.09e-03 | 114 | 113 | 4 | PS50268 | |
| Domain | - | 5.09e-03 | 114 | 113 | 4 | 2.60.40.60 | |
| Domain | CA | 5.25e-03 | 115 | 113 | 4 | SM00112 | |
| Domain | Cadherin-like | 5.41e-03 | 116 | 113 | 4 | IPR015919 | |
| Domain | Cadherin | 5.75e-03 | 118 | 113 | 4 | IPR002126 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 7.71e-05 | 16 | 75 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 9.32e-05 | 17 | 75 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.80e-04 | 21 | 75 | 3 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.37e-04 | 23 | 75 | 3 | M556 | |
| Pubmed | 4.71e-10 | 83 | 119 | 8 | 28794006 | ||
| Pubmed | RBM11 TCF20 GATAD2A HIPK2 SMG5 CEP192 PATL1 SIX4 ADNP INO80D BLM KMT2D SALL2 GSE1 NFATC3 NFIC PRRC2C TNRC6A KMT2A RPRD2 ELF4 HAL TBP | 5.42e-10 | 1429 | 119 | 23 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TFEB GAPVD1 TCF20 CEP192 CCDC88C NHSL1 NFATC3 PRRC2C N4BP2 KIAA1217 TET1 CCSER2 KMT2A BOD1L1 TANC1 PALLD CNOT4 AGAP3 | 9.10e-10 | 861 | 119 | 18 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TFEB RBM11 HIPK2 ZDBF2 CEP192 BLM SALL2 GSE1 NFATC3 PRRC2C N4BP2 KIAA1217 BUB1 TNRC6A TANC1 | 1.82e-09 | 588 | 119 | 15 | 38580884 |
| Pubmed | RBM11 GAPVD1 TCF20 ZDBF2 ADNP KMT2D SALL2 GSE1 N4BP2 TET1 BUB1 TNRC6A | 2.32e-08 | 418 | 119 | 12 | 34709266 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TFEB SOX30 KIAA1549 TSC22D2 SIX4 ADNP KMT2D SALL2 NFATC3 NFIC TOX3 KMT2A ELF4 DLX2 GRHL3 | 5.28e-07 | 908 | 119 | 15 | 19274049 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TFEB PDE4A SZT2 NSD1 SMG5 CEP192 TEP1 CCDC88C NHSL1 CELSR1 HEG1 KMT2D DLX2 WDR90 TANC1 AGAP3 | 1.21e-06 | 1105 | 119 | 16 | 35748872 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GAPVD1 TROAP CEP192 PATL1 CCDC88C HROB NFATC3 N4BP2 KIAA1217 SIMC1 TNRC6A TANC1 NEURL4 CNOT4 | 1.40e-06 | 853 | 119 | 14 | 28718761 |
| Pubmed | GAPVD1 SZT2 KIAA1549 SMG5 ADNP HECW2 TET1 CCSER2 TNRC6A RPRD2 WDR90 | 2.18e-06 | 529 | 119 | 11 | 14621295 | |
| Pubmed | GAPVD1 TCF20 NSD1 ADNP KMT2D PRRC2C TET1 KMT2A RPRD2 BOD1L1 PALLD | 3.12e-06 | 549 | 119 | 11 | 38280479 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.33e-06 | 123 | 119 | 6 | 26912792 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 4.76e-06 | 125 | 119 | 6 | 32891193 | |
| Pubmed | GATAD2A ZNF831 KMT2D PRRC2C N4BP2 TNRC6A KMT2A BOD1L1 MUC4 NUP160 | 5.19e-06 | 469 | 119 | 10 | 27634302 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GAPVD1 GATAD2A SMG5 SIX4 ADNP BLM KMT2D SALL2 GSE1 NFIC PRRC2C NUP160 TBP | 7.97e-06 | 857 | 119 | 13 | 25609649 |
| Pubmed | 8.11e-06 | 209 | 119 | 7 | 36779422 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | GATAD2A TROAP ADNP INO80D KMT2D GSE1 TET1 KMT2A BOD1L1 ZNF292 | 8.31e-06 | 495 | 119 | 10 | 27705803 |
| Pubmed | Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. | 1.16e-05 | 2 | 119 | 2 | 23100278 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12124344 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21615302 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19144982 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24323992 | ||
| Pubmed | Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo. | 1.16e-05 | 2 | 119 | 2 | 26711341 | |
| Pubmed | Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival. | 1.16e-05 | 2 | 119 | 2 | 31435991 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24423662 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23544943 | ||
| Pubmed | 2.30e-05 | 339 | 119 | 8 | 30415952 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBM11 PCBP3 TCF20 GATAD2A NSD1 ZDBF2 ADNP BLM PRRC2C SIMC1 KMT2A RPRD2 BOD1L1 | 2.46e-05 | 954 | 119 | 13 | 36373674 |
| Pubmed | PDE4A TCF20 PRR36 NSD1 ADNP ITIH1 CCDC88C NFATC3 FAM120C PRRC2C N4BP2 KIAA1217 NEURL4 | 2.71e-05 | 963 | 119 | 13 | 28671696 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.07e-05 | 18 | 119 | 3 | 18834073 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23053434 | ||
| Pubmed | Adipose-derived stem cell exosome NFIC improves diabetic foot ulcers by regulating miR-204-3p/HIPK2. | 3.47e-05 | 3 | 119 | 2 | 37710299 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 30236127 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 26902498 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 3.47e-05 | 3 | 119 | 2 | 17592322 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23932714 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23192982 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 22829784 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 31592798 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 32977948 | ||
| Pubmed | Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs. | 3.47e-05 | 3 | 119 | 2 | 29793420 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 35879412 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 12646957 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 27483328 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 24204560 | ||
| Pubmed | Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. | 3.47e-05 | 3 | 119 | 2 | 30315824 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 24939955 | ||
| Pubmed | 3.56e-05 | 263 | 119 | 7 | 34702444 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.78e-05 | 180 | 119 | 6 | 35198878 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 4.78e-05 | 608 | 119 | 10 | 36089195 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FUT10 PCDH11Y HIPK2 CEP192 PATL1 TEP1 HIPK3 FAM120C NFIC KIAA1217 TOX3 RPRD2 BOD1L1 TANC1 RECK AGAP3 | 4.95e-05 | 1489 | 119 | 16 | 28611215 |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 5.74e-05 | 22 | 119 | 3 | 26886794 | |
| Pubmed | 5.77e-05 | 119 | 119 | 5 | 23508102 | ||
| Pubmed | 6.58e-05 | 23 | 119 | 3 | 9225980 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 22863532 | ||
| Pubmed | Estrogenic induction of spermatogenesis in the hypogonadal mouse. | 6.93e-05 | 4 | 119 | 2 | 10919273 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 37722486 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 6.93e-05 | 4 | 119 | 2 | 23129768 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 24081332 | ||
| Pubmed | Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia. | 6.93e-05 | 4 | 119 | 2 | 26791235 | |
| Pubmed | Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. | 6.93e-05 | 4 | 119 | 2 | 34785661 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 6.93e-05 | 4 | 119 | 2 | 39024979 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 25630557 | ||
| Pubmed | SECISBP2L PATL1 RGS3 GSE1 PRRC2C BUB1 KMT2A TANC1 PALLD CNOT4 | 8.32e-05 | 650 | 119 | 10 | 38777146 | |
| Pubmed | 8.50e-05 | 25 | 119 | 3 | 32528060 | ||
| Pubmed | 1.15e-04 | 5 | 119 | 2 | 26320581 | ||
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 1.15e-04 | 5 | 119 | 2 | 28609655 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TFEB TCF20 GATAD2A NSD1 SIX4 ADNP INO80D BLM KMT2D TBRG1 NFIC KMT2A RPRD2 ELF4 | 1.41e-04 | 1294 | 119 | 14 | 30804502 |
| Pubmed | 1.45e-04 | 77 | 119 | 4 | 10835267 | ||
| Pubmed | 1.56e-04 | 446 | 119 | 8 | 24255178 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.69e-04 | 80 | 119 | 4 | 10716726 | |
| Pubmed | Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. | 1.73e-04 | 6 | 119 | 2 | 9111364 | |
| Pubmed | Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. | 1.73e-04 | 6 | 119 | 2 | 24176642 | |
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 34933446 | ||
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 19329795 | ||
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 12529400 | ||
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 1.73e-04 | 6 | 119 | 2 | 16199523 | |
| Pubmed | Epidermal wound repair is regulated by the planar cell polarity signaling pathway. | 1.73e-04 | 6 | 119 | 2 | 20643356 | |
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 20579985 | ||
| Pubmed | 1.73e-04 | 6 | 119 | 2 | 9748262 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.79e-04 | 341 | 119 | 7 | 32971831 | |
| Pubmed | 1.83e-04 | 152 | 119 | 5 | 38360978 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.86e-04 | 583 | 119 | 9 | 29844126 | |
| Pubmed | 1.88e-04 | 153 | 119 | 5 | 10718198 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PCBP3 SMG5 PATL1 TBRG1 FAM120C PRRC2C TNRC6A WDR77 PALLD ZNF292 | 1.99e-04 | 724 | 119 | 10 | 36232890 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.14e-04 | 351 | 119 | 7 | 38297188 | |
| Pubmed | 2.29e-04 | 472 | 119 | 8 | 38943005 | ||
| Pubmed | 2.33e-04 | 87 | 119 | 4 | 12465718 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 36598580 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 19219072 | ||
| Pubmed | 2.41e-04 | 7 | 119 | 2 | 23535175 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 2.82e-04 | 167 | 119 | 5 | 20362541 | |
| Pubmed | 3.21e-04 | 8 | 119 | 2 | 25284789 | ||
| Pubmed | Common variants in the trichohyalin gene are associated with straight hair in Europeans. | 3.21e-04 | 8 | 119 | 2 | 19896111 | |
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 3.21e-04 | 8 | 119 | 2 | 22722839 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 3.21e-04 | 8 | 119 | 2 | 23130995 | |
| Pubmed | 3.21e-04 | 8 | 119 | 2 | 22266653 | ||
| Pubmed | 3.32e-04 | 268 | 119 | 6 | 33640491 | ||
| Pubmed | 3.59e-04 | 272 | 119 | 6 | 31010829 | ||
| Pubmed | 4.11e-04 | 9 | 119 | 2 | 22665483 | ||
| Pubmed | 4.11e-04 | 9 | 119 | 2 | 24930734 | ||
| Interaction | NUP43 interactions | RBM11 PCBP3 TCF20 GATAD2A SZT2 NSD1 ZDBF2 BLM KMT2D SALL2 GSE1 PRRC2C TOX3 CCSER2 KMT2A ELF4 BOD1L1 NUP160 ZNF292 | 2.16e-09 | 625 | 114 | 19 | int:NUP43 |
| Interaction | SMG7 interactions | SECISBP2L RBM11 TCF20 ZDBF2 SMG5 PATL1 SIX4 KMT2D SALL2 GSE1 FAM120C TET1 TNRC6A RPRD2 | 3.52e-09 | 319 | 114 | 14 | int:SMG7 |
| Interaction | R3HDM2 interactions | 7.06e-07 | 129 | 114 | 8 | int:R3HDM2 | |
| Interaction | ZYX interactions | SECISBP2L HIPK2 CEP192 TSC22D2 TIPARP HIPK3 N4BP2 KIAA1217 BUB1 TNRC6A TANC1 | 2.68e-06 | 329 | 114 | 11 | int:ZYX |
| Interaction | NUP50 interactions | TCF20 NSD1 BIRC3 TIPARP BLM GSE1 KMT2A RPRD2 BOD1L1 NUP160 ZNF292 | 3.78e-06 | 341 | 114 | 11 | int:NUP50 |
| Interaction | LZTS2 interactions | TROAP HIPK2 SMG5 CEP192 PATL1 UBASH3A HROB ZNF648 N4BP2 KIAA1217 CCSER2 TNRC6A AGAP3 | 6.60e-06 | 512 | 114 | 13 | int:LZTS2 |
| Interaction | CNOT9 interactions | 6.67e-06 | 231 | 114 | 9 | int:CNOT9 | |
| Interaction | CNOT2 interactions | 7.85e-06 | 178 | 114 | 8 | int:CNOT2 | |
| Interaction | CXXC1 interactions | 1.01e-05 | 132 | 114 | 7 | int:CXXC1 | |
| Interaction | ASF1A interactions | 1.22e-05 | 249 | 114 | 9 | int:ASF1A | |
| Interaction | SOX2 interactions | TFEB TCF20 GATAD2A GNPTAB NSD1 ZDBF2 SIX4 ADNP ITIH1 ZNF169 TIPARP CELSR1 KMT2D SALL2 GSE1 NFIC KIAA1217 TNRC6A KMT2A BOD1L1 HAL ZNF292 | 1.34e-05 | 1422 | 114 | 22 | int:SOX2 |
| Interaction | DAZL interactions | 1.87e-05 | 145 | 114 | 7 | int:DAZL | |
| Interaction | PHF21A interactions | 2.54e-05 | 343 | 114 | 10 | int:PHF21A | |
| Interaction | RNF214 interactions | 2.77e-05 | 104 | 114 | 6 | int:RNF214 | |
| Interaction | POLR1E interactions | 3.02e-05 | 350 | 114 | 10 | int:POLR1E | |
| Interaction | TNRC6A interactions | 3.08e-05 | 280 | 114 | 9 | int:TNRC6A | |
| Interaction | PCM1 interactions | RBM11 PCBP3 SMG5 CEP192 TIPARP CDKL5 FAM120C KIAA1217 WDR90 TANC1 NEURL4 | 3.58e-05 | 434 | 114 | 11 | int:PCM1 |
| Interaction | CCDC6 interactions | 3.63e-05 | 286 | 114 | 9 | int:CCDC6 | |
| Interaction | KDM6A interactions | 3.81e-05 | 162 | 114 | 7 | int:KDM6A | |
| Interaction | CEP85 interactions | 4.99e-05 | 169 | 114 | 7 | int:CEP85 | |
| Interaction | UBAP2L interactions | 5.00e-05 | 298 | 114 | 9 | int:UBAP2L | |
| Interaction | BAG2 interactions | TFEB GAPVD1 TCF20 ADNP TEP1 TIPARP SALL2 PRRC2C BUB1 RPRD2 BOD1L1 WDR77 PALLD | 5.07e-05 | 622 | 114 | 13 | int:BAG2 |
| Interaction | ACTR5 interactions | 5.49e-05 | 72 | 114 | 5 | int:ACTR5 | |
| Interaction | TLE3 interactions | 5.52e-05 | 376 | 114 | 10 | int:TLE3 | |
| Interaction | SP7 interactions | 5.83e-05 | 304 | 114 | 9 | int:SP7 | |
| Interaction | EYA2 interactions | 6.50e-05 | 121 | 114 | 6 | int:EYA2 | |
| Interaction | PATL1 interactions | 6.69e-05 | 177 | 114 | 7 | int:PATL1 | |
| Interaction | ZFP36 interactions | 7.69e-05 | 181 | 114 | 7 | int:ZFP36 | |
| Interaction | LHX3 interactions | 8.83e-05 | 185 | 114 | 7 | int:LHX3 | |
| Interaction | HROB interactions | 1.01e-04 | 43 | 114 | 4 | int:HROB | |
| Interaction | FAM120C interactions | 1.08e-04 | 191 | 114 | 7 | int:FAM120C | |
| Interaction | AFDN interactions | BIRC3 CEP192 TIPARP CCDC88C CDKL5 KIAA1217 TNRC6A KMT2A MTUS2 | 1.17e-04 | 333 | 114 | 9 | int:AFDN |
| Interaction | YWHAH interactions | TFEB GAPVD1 TCF20 CEP192 CCDC88C NHSL1 NFATC3 PRRC2C KIAA1217 TET1 CCSER2 KMT2A BOD1L1 TANC1 PALLD CNOT4 AGAP3 | 1.51e-04 | 1102 | 114 | 17 | int:YWHAH |
| Interaction | BICD2 interactions | CEP192 PATL1 HROB NFATC3 ZNF648 KIAA1217 TNRC6A TANC1 NEURL4 NUP160 | 1.54e-04 | 426 | 114 | 10 | int:BICD2 |
| Interaction | ZMYM2 interactions | 1.55e-04 | 271 | 114 | 8 | int:ZMYM2 | |
| Interaction | MAPRE1 interactions | TROAP BIRC3 PATL1 TIPARP PRRC2C KIAA1217 CCSER2 WDR90 TANC1 NUP160 MTUS2 | 1.61e-04 | 514 | 114 | 11 | int:MAPRE1 |
| Interaction | NCOA6 interactions | 1.76e-04 | 145 | 114 | 6 | int:NCOA6 | |
| Interaction | RBMS1 interactions | 1.77e-04 | 207 | 114 | 7 | int:RBMS1 | |
| Interaction | CNOT6L interactions | 1.85e-04 | 93 | 114 | 5 | int:CNOT6L | |
| Interaction | TNRC6B interactions | 2.04e-04 | 282 | 114 | 8 | int:TNRC6B | |
| Interaction | TOP3B interactions | TFEB RBM11 PDE4A SZT2 NSD1 APOB SMG5 CEP192 PATL1 TEP1 CCDC88C NHSL1 CELSR1 HEG1 KMT2D FAM120C DLX2 WDR90 TANC1 AGAP3 | 2.05e-04 | 1470 | 114 | 20 | int:TOP3B |
| Interaction | RBBP5 interactions | 2.29e-04 | 287 | 114 | 8 | int:RBBP5 | |
| Interaction | CPEB4 interactions | 2.62e-04 | 156 | 114 | 6 | int:CPEB4 | |
| Interaction | KDM1A interactions | RBM11 GAPVD1 TCF20 BIRC3 ZDBF2 ADNP TIPARP KMT2D SALL2 GSE1 N4BP2 KIAA1217 TET1 BUB1 TNRC6A | 2.70e-04 | 941 | 114 | 15 | int:KDM1A |
| Interaction | CCT8L2 interactions | 2.71e-04 | 157 | 114 | 6 | int:CCT8L2 | |
| Interaction | SOX6 interactions | 2.71e-04 | 157 | 114 | 6 | int:SOX6 | |
| Interaction | NINL interactions | TROAP CEP192 CCDC88C GSE1 KIAA1217 TNRC6A RPRD2 TANC1 DMBT1 PALLD | 2.76e-04 | 458 | 114 | 10 | int:NINL |
| Interaction | DCAF4 interactions | SECISBP2L RBM11 SOX30 HIPK2 PATL1 FAM120C N4BP2 CCSER2 TNRC6A | 3.00e-04 | 378 | 114 | 9 | int:DCAF4 |
| Interaction | ANKRD17 interactions | 3.03e-04 | 226 | 114 | 7 | int:ANKRD17 | |
| Interaction | EIF4ENIF1 interactions | 3.09e-04 | 300 | 114 | 8 | int:EIF4ENIF1 | |
| Interaction | SOX5 interactions | 3.21e-04 | 162 | 114 | 6 | int:SOX5 | |
| Interaction | ZNF280D interactions | 3.27e-04 | 24 | 114 | 3 | int:ZNF280D | |
| Interaction | DCP1A interactions | 3.65e-04 | 166 | 114 | 6 | int:DCP1A | |
| Interaction | PRRC2A interactions | SECISBP2L RBM11 SMG5 CEP192 TIPARP FAM120C PRRC2C TNRC6A WDR77 | 3.70e-04 | 389 | 114 | 9 | int:PRRC2A |
| Interaction | KIAA0586 interactions | 3.70e-04 | 25 | 114 | 3 | int:KIAA0586 | |
| Interaction | GARRE1 interactions | 3.77e-04 | 167 | 114 | 6 | int:GARRE1 | |
| Interaction | KMT2D interactions | 4.02e-04 | 169 | 114 | 6 | int:KMT2D | |
| Cytoband | 22q13.3 | 9.93e-05 | 6 | 119 | 2 | 22q13.3 | |
| GeneFamily | CD molecules|Mucins | 6.45e-05 | 21 | 68 | 3 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.10e-04 | 25 | 68 | 3 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.80e-04 | 34 | 68 | 3 | 487 | |
| GeneFamily | Zinc fingers CXXC-type | 8.98e-04 | 12 | 68 | 2 | 136 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L GAPVD1 DUSP1 TSC22D2 ADNP TIPARP BLM HEG1 GSE1 NFATC3 PRRC2C CCSER2 NUP160 CNOT4 ZNF292 | 5.81e-06 | 856 | 116 | 15 | M4500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | TFEB PRR36 ZSWIM5 TIPARP BLM CCDC88C BMP5 CELSR1 KIAA1217 TOX3 DLX2 WDR77 | 1.22e-05 | 491 | 113 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_500 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-08 | 195 | 119 | 8 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-06 | 155 | 119 | 6 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.75e-06 | 161 | 119 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.86e-06 | 167 | 119 | 6 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.28e-06 | 169 | 119 | 6 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.72e-06 | 171 | 119 | 6 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-06 | 177 | 119 | 6 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-06 | 177 | 119 | 6 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.45e-06 | 178 | 119 | 6 | a28683690ab8a60eb18f3ef87ea85da4e95b22df | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-06 | 179 | 119 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.08e-05 | 186 | 119 | 6 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 189 | 119 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-05 | 190 | 119 | 6 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-05 | 190 | 119 | 6 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.22e-05 | 190 | 119 | 6 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-05 | 190 | 119 | 6 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.22e-05 | 190 | 119 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.30e-05 | 192 | 119 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 193 | 119 | 6 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-05 | 194 | 119 | 6 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-05 | 195 | 119 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.46e-05 | 196 | 119 | 6 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 197 | 119 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.55e-05 | 198 | 119 | 6 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.59e-05 | 199 | 119 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.64e-05 | 200 | 119 | 6 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-05 | 200 | 119 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.64e-05 | 200 | 119 | 6 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.64e-05 | 200 | 119 | 6 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-05 | 200 | 119 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 132 | 119 | 5 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.60e-05 | 139 | 119 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 149 | 119 | 5 | a6e192bf9bcf3b219e618c465bc451f7c86f49f1 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.15e-05 | 76 | 119 | 4 | df1c29cf88b1957e210058e172683f78a1eea2bd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-05 | 152 | 119 | 5 | aa88084ba1851d879ece82baa516f6b46cbd2eb8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 6.06e-05 | 155 | 119 | 5 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.83e-05 | 159 | 119 | 5 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Club_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 7.91e-05 | 164 | 119 | 5 | 4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-05 | 167 | 119 | 5 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 9.37e-05 | 170 | 119 | 5 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-04 | 173 | 119 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 175 | 119 | 5 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 175 | 119 | 5 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.10e-04 | 176 | 119 | 5 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.13e-04 | 177 | 119 | 5 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 177 | 119 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.19e-04 | 179 | 119 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 179 | 119 | 5 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 180 | 119 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 180 | 119 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 180 | 119 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-04 | 181 | 119 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.26e-04 | 181 | 119 | 5 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 182 | 119 | 5 | 626aabfd9ac662c1d189f7c4b660482914d9e669 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 182 | 119 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 182 | 119 | 5 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 182 | 119 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 182 | 119 | 5 | a00abff41c12b71d5860c494b8c722d649fd5f36 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-04 | 182 | 119 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 183 | 119 | 5 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 183 | 119 | 5 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 1.32e-04 | 183 | 119 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 183 | 119 | 5 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 1.32e-04 | 183 | 119 | 5 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.32e-04 | 183 | 119 | 5 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 184 | 119 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 1.36e-04 | 184 | 119 | 5 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 184 | 119 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.36e-04 | 184 | 119 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 185 | 119 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 185 | 119 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 186 | 119 | 5 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.43e-04 | 186 | 119 | 5 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 186 | 119 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.43e-04 | 186 | 119 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 187 | 119 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 187 | 119 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 187 | 119 | 5 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 188 | 119 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 188 | 119 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 188 | 119 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 188 | 119 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 188 | 119 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.58e-04 | 190 | 119 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.62e-04 | 191 | 119 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 191 | 119 | 5 | e94dfd2d8da81bfd16f2f1a4f3ac27b078eeb3ca | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-04 | 192 | 119 | 5 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 192 | 119 | 5 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-04 | 192 | 119 | 5 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 1.65e-04 | 192 | 119 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-04 | 192 | 119 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 193 | 119 | 5 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 193 | 119 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 193 | 119 | 5 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.45e-07 | 191 | 119 | 9 | 6236_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.66e-06 | 166 | 119 | 8 | 4327_UP | |
| Drug | zeolites | 8.24e-06 | 25 | 119 | 4 | CID006432059 | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 8.73e-06 | 195 | 119 | 8 | 4324_DN | |
| Drug | torcetrapib | DUSP1 HIPK2 PATL1 INO80D TIPARP PRRC2C CCSER2 KMT2A BOD1L1 PALLD | 1.28e-05 | 342 | 119 | 10 | ctd:C483909 |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.15e-05 | 160 | 119 | 7 | 5275_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.33e-05 | 162 | 119 | 7 | 7340_UP | |
| Drug | etioporphyrin | 2.71e-05 | 2 | 119 | 2 | CID000079013 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A | 2.83e-05 | 167 | 119 | 7 | 6680_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.17e-05 | 170 | 119 | 7 | 4680_UP | |
| Disease | Weaver syndrome | 1.49e-04 | 5 | 115 | 2 | C0265210 | |
| Disease | LDL cholesterol change measurement | 3.12e-04 | 7 | 115 | 2 | EFO_0007804 | |
| Disease | cathepsin Z measurement | 4.15e-04 | 8 | 115 | 2 | EFO_0008074 | |
| Disease | common bile duct neoplasm (is_marker_for) | 4.15e-04 | 8 | 115 | 2 | DOID:4608 (is_marker_for) | |
| Disease | apolipoprotein A 1 measurement | MGAM NSD1 OR5T2 APOB TSHR TSC22D2 PKD1L3 ITIH1 NFATC3 NFIC KMT2A | 4.88e-04 | 848 | 115 | 11 | EFO_0004614 |
| Disease | Neurodevelopmental Disorders | 4.89e-04 | 93 | 115 | 4 | C1535926 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 6.64e-04 | 10 | 115 | 2 | OBA_2045163 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 8.09e-04 | 11 | 115 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | neuroimaging measurement | SECISBP2L ZNF438 GATAD2A SZT2 TSC22D2 CCDC88C NHSL1 CELSR1 PRRC2C TOX3 TNRC6A AGAP3 | 9.64e-04 | 1069 | 115 | 12 | EFO_0004346 |
| Disease | pulse pressure measurement | ZNF438 FUT10 PCBP3 GATAD2A HEATR5A TSC22D2 PKD1L3 ZNF831 ITIH1 KIAA1217 TET1 TNRC6A PALLD NUP160 | 1.05e-03 | 1392 | 115 | 14 | EFO_0005763 |
| Disease | Small cell carcinoma of lung | 1.24e-03 | 54 | 115 | 3 | C0149925 | |
| Disease | leukemia | 1.31e-03 | 55 | 115 | 3 | C0023418 | |
| Disease | cognitive function measurement | ZNF438 PCBP3 TCF20 SZT2 ZDBF2 CEP192 TSC22D2 PKD1L3 RGS3 KMT2D PRRC2C KIAA1217 TNRC6A CNOT4 | 1.39e-03 | 1434 | 115 | 14 | EFO_0008354 |
| Disease | amygdala volume change measurement | 1.74e-03 | 16 | 115 | 2 | EFO_0021490 | |
| Disease | cortical surface area measurement | ZNF438 ITGA11 HIPK2 TSC22D2 CCDC88C NHSL1 CELSR1 PRRC2C TOX3 TNRC6A LINC00574 CNOT4 AGAP3 | 2.26e-03 | 1345 | 115 | 13 | EFO_0010736 |
| Disease | pantothenic acid mesurement | 2.73e-03 | 20 | 115 | 2 | EFO_0010519 | |
| Disease | progression free survival, ovarian serous carcinoma | 3.31e-03 | 22 | 115 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Autistic Disorder | 3.63e-03 | 261 | 115 | 5 | C0004352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIFHAPNASAPSSSL | 126 | Q9H2P0 | |
| LPNSPSHSAVSAASI | 266 | Q96P47 | |
| TPFSTPSHLFTLHLQ | 316 | Q9N2K0 | |
| TSAAQLASTPFHKLP | 601 | O43683 | |
| PSLISNHGIFSLPSS | 466 | Q14687 | |
| PNLFDSSIVPSFHSL | 746 | Q86UQ4 | |
| PTFPSSVTNSTHSLL | 111 | Q13489 | |
| AAQHSALAAPTTLPA | 141 | Q9NYQ6 | |
| SHLQATAPLLHPTQT | 291 | Q07687 | |
| LIASQRSSASAIHPP | 786 | Q5JR59 | |
| LPNSASVSSSLNHVP | 206 | P57052 | |
| KPLLFSSASSQNHIP | 886 | Q96L73 | |
| NRSHSDSTPLPNFLS | 26 | P49796 | |
| QHTLPALSRATAPTD | 451 | P49796 | |
| SLINSDSPTLASHVP | 911 | O95980 | |
| LSTPPSSNVNSIYHT | 331 | Q7Z3E1 | |
| GPVDNTHILSPVSSF | 401 | Q9HCM3 | |
| ISPEFFTVLHSNPSA | 926 | Q9P2P5 | |
| VLHTFSPSPKLQNSA | 541 | Q86YP4 | |
| ATLILSQHCTSQPSP | 471 | P19113 | |
| PATSQLPFSIGHITS | 3771 | Q8WXI7 | |
| SSLPPKISTAFHTQQ | 441 | Q99102 | |
| AATPALSNPHLTAVL | 666 | Q86TB9 | |
| LPSSFHSPKQDNIIS | 261 | A6NM03 | |
| TPFITHVAPSTSTNL | 566 | Q9H2X6 | |
| NITTSNLKASHSPPL | 61 | Q8N387 | |
| NLSHLPTFSSPAIES | 376 | Q3T906 | |
| RTFVLSALQPSPTHS | 641 | P19827 | |
| SASSVPSNIHLGVAP | 396 | Q99607 | |
| LISVSPANRSSVHPA | 316 | A6NL99 | |
| SLKSSVHANAFPSTP | 1916 | O43451 | |
| TSSQATQPGPALLSH | 191 | Q86X51 | |
| DPTLLHQSQSSSSFP | 401 | Q6ZUT3 | |
| AHQLTSPPSQSESLL | 811 | Q14C86 | |
| SPEPTHLLSSLSSFQ | 541 | Q8N187 | |
| LAPLHQSATAPAIAT | 1896 | Q9P219 | |
| VSPHATYSTSIIPNA | 406 | Q5SYE7 | |
| IFLQSRFSPPHSSLN | 551 | Q3V5L5 | |
| PLSSPVHLDFSSASL | 91 | Q96RD9 | |
| PQSTAPGLFLVSTHT | 611 | Q9Y5F6 | |
| VSHSSPSALALQSPL | 806 | P27815 | |
| TARPQSSALHPLLTF | 126 | Q8N3J3 | |
| LPLPSVSQSHHLFSS | 676 | Q9ULI3 | |
| TPIFLAPHFQTTTVG | 676 | Q9UKX5 | |
| PTFTFHVNPVLSSRL | 231 | Q68DD2 | |
| TLSSAAPVAHLLASP | 1126 | Q9H422 | |
| STLSTLSHHPQPQFG | 16 | P57721 | |
| HSQTPAAFLSALLPS | 846 | Q8WX93 | |
| APHILYPTSTNSSAA | 576 | Q9Y5I4 | |
| STSPADHSALPNQSL | 1316 | Q8NFC6 | |
| HSIQNSFLPPSSITR | 226 | Q9H7U1 | |
| SFLPPSSITRSHSFN | 231 | Q9H7U1 | |
| STPEFTILNTFHIPS | 2646 | P04114 | |
| FFSRSPAHSISPLLQ | 116 | Q96M78 | |
| SRPLSPTAFSLQFLH | 631 | P42357 | |
| LSLASPSHPKATQTQ | 331 | Q86XA9 | |
| DLDSNPSPTTVNSLH | 606 | Q8TE85 | |
| KELNFSHLPSNSVSP | 451 | P54132 | |
| FPVSIPVHSTNSALS | 341 | P28562 | |
| PVHSTNSALSYLQSP | 346 | P28562 | |
| SPALNHNSTSPLTLA | 426 | Q9BQN1 | |
| PSNKSAILVSEFSHP | 316 | Q6P4F1 | |
| PSQHPVLSSNLADSS | 56 | Q9H8X3 | |
| PVGPNSSLLFSSHAL | 461 | Q9NX05 | |
| TTQSPPLASLHDTNF | 136 | P22003 | |
| AVHALLTQPSLSAAP | 1246 | Q8TEP8 | |
| PQQHSHLSPLSTSLK | 206 | Q53TQ3 | |
| VTSPHLPVTQHLSSF | 351 | Q1MX18 | |
| ALNPTFTFPSHSLTQ | 791 | Q03164 | |
| LSPLHTKTYQASSQP | 376 | O76039 | |
| SGNHLSTPAPFLNIT | 1986 | Q9UGM3 | |
| HRSLFSPQNTLAAPT | 971 | Q5VT52 | |
| DQLIASPHLAFPSTT | 311 | Q9Y467 | |
| NTATEKSFPLHSPVA | 896 | Q96JN8 | |
| LVFSPHSVPFLASLS | 261 | Q9BQA1 | |
| PLAQAAAISHSSSLP | 1241 | Q9BZA8 | |
| ETPFSQHLSSSPVLQ | 316 | Q6NXP6 | |
| IFRTQFLDHPSPSSA | 1266 | Q5T011 | |
| PNTLPLSSSHLNVYS | 181 | P19484 | |
| HLQSSFPVLSPAFLS | 356 | B4DYI2 | |
| TFSNLLLQPTTNPHT | 586 | Q9UPR3 | |
| SHLQTIPSDLTSFPA | 876 | Q14C87 | |
| HSAPTSLPQSDLSQF | 566 | O75157 | |
| HPLQALSSLASHSPQ | 686 | Q9H6K5 | |
| HPISQFPSVLSSITS | 201 | Q7Z443 | |
| PSVVLSGTAIHNFPT | 2481 | Q9Y520 | |
| ASSSHIAQEASPRPL | 1701 | Q5T5P2 | |
| LVNVSPTHNFSLSPS | 611 | Q9UIU6 | |
| ILKASSSHPSSQPNL | 641 | Q8NDZ2 | |
| QDLHFTPLLSPSSST | 456 | Q9C0D5 | |
| PSQLGQVFPLSSHRS | 151 | Q93073 | |
| LTFTAPAPHTSTSQI | 1366 | A1L4H1 | |
| SALHFPTTSILPQTA | 371 | P08651 | |
| ISHLFSQPKAPLSQT | 836 | Q12769 | |
| PPLLAISYSDTHTNQ | 221 | Q8NGG2 | |
| STAHARFATSTIQPP | 551 | O94993 | |
| HQPSFLTSPQDLASS | 1941 | Q8NFU7 | |
| LSKSNPVIPISSSNH | 306 | O95628 | |
| TTETQGHLPPSLAAF | 1626 | Q96KV7 | |
| TNALPQSAIHSPDSL | 466 | Q9P217 | |
| AHFSPISFSTLTPTI | 1241 | A4D1E1 | |
| TVSASPLFQSLQISH | 121 | Q99973 | |
| LFHSQTLTTAPLPGT | 121 | P20226 | |
| FPLHPVASFSNSTKA | 411 | P47872 | |
| IFPAHLASVSTPLLS | 1191 | O60281 | |
| TANTTSLPPAAHLDS | 201 | Q9HCK1 | |
| APATTSLIFSSQHPL | 666 | Q12815 | |
| GLPSHSSVLSPSFQL | 66 | Q12968 | |
| NSHSSPFTAVLLLVT | 331 | Q8TCU3 | |
| PLSQHGTVSASPQTL | 361 | O15405 | |
| SSLHTPFSPNSETLA | 1046 | Q9UGU0 | |
| THTPAQASATPASLA | 206 | Q5T619 | |
| TLTATSVPSFINHPL | 66 | O95900 | |
| RPLFFHSVPTQLSTT | 481 | Q5JPB2 | |
| GTHQFASVPVRSSPL | 1916 | Q07283 | |
| TFSLVALPHVASAQP | 91 | Q7Z4V0 | |
| VQAAAPSHSSSLPLT | 91 | Q3YBR2 | |
| SSPSPINAFLSVDHL | 1941 | Q8NDV7 | |
| ALSGHPTQIFPSSSA | 111 | Q14929 | |
| SFPTAVPLALHSSIS | 141 | P57075 | |
| TIPSHAFSNLPNISR | 66 | P16473 | |
| EASSVPHLLAQPSVS | 4126 | O14686 | |
| QHTSLPLTFTNSAPT | 971 | Q86UW6 |